alexa <p>A Novel Resveratrol Tetramer Vaticanol C from Stem Bark Acts as an Antimetastatic Action in a Mouse Mammary Cancer Model</p> | OMICS International
ISSN: 2327-5162
Alternative & Integrative Medicine
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

A Novel Resveratrol Tetramer Vaticanol C from Stem Bark Acts as an Antimetastatic Action in a Mouse Mammary Cancer Model

Masa-Aki Shibata1*, Yukihiro Akao2 and Munekazu Iinuma3

1Laboratory of Anatomy and Histopathology, Graduate School of Health Sciences, Osaka Health Science University, Japan

2United Graduate School of Drug Discovery and Medical Information Science, Gifu University, Gifu, Japan

3Gifu Pharmaceutical University, Gifu, Japan

*Corresponding Author:
Shibata MA
Laboratory of Anatomy and Histopathology
Graduate School of Health Sciences
Osaka Health Science University, 1-9-27 Temma, Kita-ku, Osaka, 530-0043, Japan
Tel: +81-6-7506-9046
Fax: +81-6-6352-5995
E-mail: [email protected]

Received date March 16, 2015; Accepted date March 18, 2015; Published date March 22, 2015

Citation: Shibata MA, Akao Y, Iinuma M (2015) A Novel Resveratrol Tetramer Vaticanol C from Stem Bark Acts as an Anti-metastatic Action in a Mouse Mammary Cancer Model . Altern Integr Med 4:e118. doi:10.4172/2327-5162.1000e118

Copyright: © 2015 Shibata MA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Alternative & Integrative Medicine

Editorial

Plants and plant extracts have been traditionally used in Ayurvedic and Chinese medicine for many centuries. A large number of natural products appear to have strong therapeutic effects and the discovery of new plants with potential biological activities is a passionate endeavor for many concerned with natural medicinal. Among those already investigated, great attention has been paid to polyphenols because of their antioxidant and possible antitumor properties [1], including α- and γ-mangostin from the mangosteen pericarp [2-4] and resveratrol. Resveratrol, a chemo preventive and therapeutic polyphenol found in grape skin and dipterocarpaceous plants [5], is one of the most famous phytochemical compounds currently under investigation. Several studies have shown that resveratrol actually possesses multiple biological activities ranging from anti-tumor functions [6] to prevention of heart disease [7].

Isolated from the stem bark of Vatica rassak in Dipterocarpacea, the resveratrol tetramer vaticanol C has shown induction of apoptotic cell death and suppression of cell proliferation in various human cancer cells [8], suggesting anti-tumoral effects. We recently demonstrated anti-metastatic effects of vaticanol C [9] in a mouse metastatic mammary cancer model carrying a p53 mutation, a model which demonstrates a metastatic spectrum similar to that seen in human breast cancers [4,10]. Here, we introduced the summary of the results on anti-metastatic abilities of vaticanol C in vitro and in vivo experiments [9].

Vaticanol C induced in vitro apoptosis, as evaluated by morphological changes, nucleosomal DNA fragmentation, and elevated activities of caspases (which are executional factors of apoptosis); similarly, apoptosis was significantly increased in vivo in mammary tumor cells exposed to 200 ppm dietary vaticanol C. Although tumor growth was similar between the control and vaticanol C-treated groups, the multiplicities of lymph node and lung metastasis were significantly reduced only in animals receiving the highest dose (200 ppm) of vaticanol C; overall metastasis to any organ also decreased, but not to a statistically significant degree over control. Cell proliferation rates tended to decrease in mammary tumors with exposure to vaticanol C in a dose-dependent manner but, again, the decrease was not statistically significant. Breast cancer is one of the most lethal cancers in humans, and death is largely due to metastasis, usually to lungs, lymph node, liver, and bone. Since lymph node involvement is the most important prognostic factor in breast cancer patients, the anti-metastatic activity of vaticanol C may be of clinical significance.

Angiogenesis in mammary tumors tended to be lower in vaticanol C-treated groups. Furthermore, the numbers of dilated lymphatic vessels having intraluminal cancer cells (an indication of lymphatic invasion) in mammary tumors were significantly decreased with administration of vaticanol C, indicating a reduction in tumor cell migration – at least, by the lymphatic route. The most common pathway of initial dissemination of many solid malignancies is via the lymphatics, with varying metastasis was found in human cancer [11].

Vaticanol C has been shown to induce apoptosis via p53-dependent pathways in a variety of cancer cells [8]. In the colon cancer cell line SW480, which carries a p53 mutation, vaticanol C induces apoptosis but reduces the transcriptional levels of mutant p53, suggesting transcriptional modulation. In the case of non-functional mutant p53, the p73 homolog may act as an apoptotic inducer. Since half of human cancers are reported to have p53 mutations [12], the fact that vaticanol C induces an apoptotic response in the presence of mutant p53 may be highly relevant to inhibiting many human cancers.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11649
  • [From(publication date):
    June-2015 - Dec 16, 2017]
  • Breakdown by view type
  • HTML page views : 7861
  • PDF downloads : 3788
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version